期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

托拉塞米治疗合并舒张性心衰的顽固性高血压临床观察 被引量：6

下载PDF
导出
摘要 顽固性高血压是指高血压患者接受健康生活方式干预及规则足量服用包括利尿剂在内的3种或3种以上降血压药物,但血压仍不能达到指南所规定的目标血压(血压不能降至140/90mmHg(1mmHg=0.133kPa)以下,或单纯收缩期高血压的收缩压不能降至140mmHg以下)者,是高血压治疗中的难点[1]。顽固性高血压的治疗,并无统一方案,由于常年血压控制不佳,患者易出现靶器官受累,部分患者会出现心功能不全,其中相当一部分为舒张性心衰。托拉塞米(torasemide)属吡啶磺酰脲类袢利尿剂,临床已使用40余年,广泛用于心衰、水肿性疾病。
作者 方晓江 赵芊 魏丽萍 彭哲 祝光礼 钱宝庆
机构地区 杭州市中医院心内科
出处 《浙江中西医结合杂志》 2014年第1期25-27,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
关键词 顽固性高血压 舒张性心衰 托拉塞米
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献5

  • 1苏绮,李一石,陈君柱,黄德嘉,樊朝美,孙兴昌,胡晓晟,陈晓平,龚培,成小如,华潞.托拉塞米治疗原发性高血压的临床评价[J].高血压杂志,2003,11(4):325-328. 被引量：12
  • 2Jan Václavík,Richard Sedlák,Martin Plachy,Karel Navrátil,Ji?í Plá?ek,Ji?í Jarkovsky,Tomá? Václavík,Roman Husár,Eva Kociánová,Milo? Táborsky.Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT): A Randomized, Double-Blind, Placebo-Controlled Trial[J].Hypertension.2011(6)
  • 3Theodore L. Goodfriend,Dennis L. Ball,Wolfgang Oelkers,Volker B?hr.Torsemide inhibits aldosterone secretion in vitro[J].Life Sciences.1998(3)
  • 4梁峰,胡大一,吴明营.顽固性高血压治疗的现状与进展[J].中华高血压杂志,2010,18(7):631-634. 被引量：21
  • 5刘国仗,胡大一,陶萍,诸骏仁,郭林妮,郭静萱,游凯.心血管药物临床试验评价方法的建议[J].中华心血管病杂志,1998,26(1):5-11. 被引量：1439

二级参考文献11

  • 1陈新谦 金有豫.新编药物学（第14版）[M].北京:人民卫生出版社,1997.487.
  • 2Cuvelier R, Pellegrin P, Lesen M, et al. Site of action of torasemide in man[J ]. Eur J Clin Phamacol, 1986,31 : 15 - 9.
  • 3Hermes H, Heridenreich O. Renal effects of torasemide in the ratclearance and micropuncture studies [ J ] . Arzneimittelforschung,1985,35:1532 - 5.
  • 4Neugebauer G, Besenfelder E, Von Moellendorff E. Pharma-cokinetica and metabolism of torasemide in man[ J ]. Arzneimittel forschung, 1988,38:161 - 6.
  • 5Barr WH, Smith HL, Karnes HT, et al. Comparison of bioavail-ability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers [ J ]. Prog Pharmacol Clin Pharmmol, 1990,8 : 15 - 28.
  • 6Spieker C, Zidek W, Hacker W, et al. Assessment of ontracellular sodium and calcitnn in essential hypertension during diuretic treatment[J]. Arzneimittel forschung, 1988,38:180 - 88.
  • 7Reyes AJ, Chiesa PD, Santucci MR, et al. Hydrochlorothiazide versus a non-diuretic dose of torasemide as once-daily antihypertensive monopharmacotherapy in elderly patients. A randomized and double-blind study[J]. Prog Pharmacol Clin Pharmmol,1990,8(1) :183-209.
  • 8Spannbrucker N, Achhammer I, Metz P, et al. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension[J ]. Arzneimittelforschung, 1988,38 : 190 - 3.
  • 9Baumgart P, Walger P, von Eiff M, et al. Long-term efficacy and tolerance of torasemide in hypertension[J]. Prog Pharmacol Clin Pharmmol, 1990,8(1) : 169 - 81 .
  • 10Achhammer I, Eberhard R. Comparison of serum potassium levels during long- term treatment of hypertensive patients with 2.5 mg torasemide/day or 50 mg triamterene/25 mg hydrochlorothiazide/day[J]. Prog Pharmacol Clin Pharmmol, 1990,8(1) :211 - 20.

共引文献1468

同被引文献88

  • 1姜红,葛均波.心力衰竭流行病学特点[J].中国医学前沿杂志（电子版）,2010,2(1):1-5. 被引量：90
  • 2巫冠中,张文平,吕正兵,刘国卿.新型磺酰脲类化合物G004对血管内皮细胞的保护作用[J].中国临床药理学与治疗学,2005,10(10):1156-1161. 被引量：2
  • 3李剑,李勇.新型袢利尿剂托拉塞米治疗心衰进展[J].药学与临床研究,2007,15(4):267-269. 被引量：22
  • 4陆春雷.吲达帕胺与双氢克尿噻抗高血压治疗的疗效和副作用观察[J].中国药物应用与监测,2007,4(6):31-32. 被引量：11
  • 5LENFANT C, CHOBANIAN AV, JONES DW, et al. Seventh report of the Joint National Committee on the prevention, detec- tion, evaluation, and treatment of high blood pressure ( JNC 7 ) : resetting the hypertension sails [ J ]. Hypertension, 2003, 41 (6) : 1178 - 1179.
  • 6DASKALOPOULOU SS, RABI DM, ZARNKE KB, et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension [ J]. Can J Cardiol, 2015, 31(5): 549 -568.
  • 7JAMES PA, OPARIL S, CARTER BL, et al. 2014 evidence- based guideline for the management of high blood pressure in a- dults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)[J]. JAMA, 2014, 311(5): 507 - 520.
  • 8RIMOLDI SF, MESSERLI FH, BANGALORE S, et al. Resist- ant hypertension: what the cardiologist needs to know [ J]. Eur Heart J, 2015, 36(40): 2686-2695.
  • 9TAMARGO J, SEGURA J, RU1LOPE LM. Diuretics in the treat- ment of hypertension. Part 1 : thiazide and thiazide-like diuretics [ J]. Expert Opin Pharmacother, 2014, 15 (4) : 527 - 547.
  • 10DORSCH MP, GILLESPIE BW, ERICKSON SR, et al. Chlortha- lidone reduces cardiovascular events compared with hydrochlo- rothiazide: a retrospective cohort analysis [ J ]. Hypertension, 2011, 57(4): 689 -694.

引证文献6

二级引证文献21

浙江中西医结合杂志
2014年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部